Related Experiment Video
Updated: May 1, 2026

09:06
Whole-brain Segmentation and Change-point Analysis of Anatomical Brain MRI—Application in Premanifest Huntington's Disease
Published on: June 9, 2018
11.0K
Quantitative 7T phase imaging in premanifest Huntington disease
A C Apple1, K L Possin2, G Satris2
1From the Departments of Radiology and Biomedical Imaging (A.C.A., J.M.L., A.J., S.J.N., C.P.H.).
AJNR. American Journal of Neuroradiology
|April 19, 2014
Summary
Ultra-high-field MRI reveals altered quantitative phase in the caudate nucleus of premanifest Huntington disease patients. This MRI technique may help monitor neurodegeneration and correlates with genetic burden and cognitive function.
Area of Science:
- Neuroimaging
- Neurodegenerative Diseases
- Biophysics
Background:
- Huntington disease (HD) is characterized by striatal iron accumulation and atrophy.
- Neuronal loss and iron are implicated in HD pathogenesis.
- Premanifest HD subjects may show early pathological changes.
Purpose of the Study:
- To investigate quantitative phase alterations in the caudate nucleus of premanifest Huntington disease (HD) using 7T MRI.
- To assess if quantitative phase reflects iron content and tissue microstructure changes in early HD.
- To correlate quantitative phase with disease burden and neurocognitive function.
Main Methods:
- 13 premanifest HD subjects and 13 controls underwent 3T and 7T MRI.
- Local field shift (quantitative phase proxy) was calculated from 7T phase images.
- Caudate regions of interest were analyzed, correlating local field shift with clinical data.
Main Results:
- Premanifest HD subjects showed smaller caudate volume and higher local field shift than controls.
- Local field shift positively correlated with genetic disease burden.
- Quantitative phase showed trends with neurocognitive tests for working memory and executive function.
Conclusions:
- 7T MRI quantitative phase is altered in the caudate nucleus of premanifest HD.
- These phase alterations correlate with genetic disease burden and neurocognitive function.
- Ultra-high-field MRI quantitative phase shows promise for monitoring HD neurodegeneration.

